JP2020500871A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500871A5
JP2020500871A5 JP2019529240A JP2019529240A JP2020500871A5 JP 2020500871 A5 JP2020500871 A5 JP 2020500871A5 JP 2019529240 A JP2019529240 A JP 2019529240A JP 2019529240 A JP2019529240 A JP 2019529240A JP 2020500871 A5 JP2020500871 A5 JP 2020500871A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
compound
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020500871A (ja
JP7649624B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/064081 external-priority patent/WO2018102616A1/en
Publication of JP2020500871A publication Critical patent/JP2020500871A/ja
Publication of JP2020500871A5 publication Critical patent/JP2020500871A5/ja
Priority to JP2022193738A priority Critical patent/JP2023029957A/ja
Application granted granted Critical
Publication of JP7649624B2 publication Critical patent/JP7649624B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529240A 2016-11-30 2017-11-30 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 Active JP7649624B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022193738A JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662428492P 2016-11-30 2016-11-30
US62/428,492 2016-11-30
US201762553313P 2017-09-01 2017-09-01
US62/553,313 2017-09-01
PCT/US2017/064081 WO2018102616A1 (en) 2016-11-30 2017-11-30 Fracture targeted bone regeneration through parathyroid hormone receptor stimulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022193738A Division JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Publications (3)

Publication Number Publication Date
JP2020500871A JP2020500871A (ja) 2020-01-16
JP2020500871A5 true JP2020500871A5 (https=) 2021-01-21
JP7649624B2 JP7649624B2 (ja) 2025-03-21

Family

ID=62241919

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529240A Active JP7649624B2 (ja) 2016-11-30 2017-11-30 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
JP2022193738A Pending JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022193738A Pending JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Country Status (10)

Country Link
US (3) US20200317745A1 (https=)
EP (1) EP3548012A4 (https=)
JP (2) JP7649624B2 (https=)
CN (1) CN110114065A (https=)
AU (1) AU2017367699B2 (https=)
BR (1) BR112019011070A2 (https=)
CA (1) CA3045458A1 (https=)
IL (1) IL266977B2 (https=)
MX (1) MX2019006189A (https=)
WO (1) WO2018102616A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3045458A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
WO2019232283A1 (en) 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
CN110551201B (zh) * 2019-08-26 2020-04-28 杭州彗搏科技有限公司 一种新型骨形成蛋白2来源的环肽、制备方法及其应用
EP4027899A4 (en) * 2019-09-12 2023-08-16 Radius Health, Inc. METHODS OF ENHANCING SPINE FUSION USING ABALOPARATIDE
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
KR20230117327A (ko) * 2020-09-03 2023-08-08 어빈 에스.와이. 첸 가용성 알칼리성 포스파타제 작제물 및 가용성 알칼리성 포스파타제 작제물을 인코딩하는 폴리뉴클레오티드를 포함하는 발현 벡터
AU2021369193A1 (en) * 2020-10-26 2023-06-01 Purdue Research Foundation Compounds,compositions and methods of use to treat spinal fusions
US20230399374A1 (en) * 2020-10-26 2023-12-14 Purdue Research Foundation Compounds, Compositions and Methods of Use to Treat Bone Fractures
WO2022149066A1 (en) * 2021-01-05 2022-07-14 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
CN118973605A (zh) * 2022-01-14 2024-11-15 普渡研究基金会 成骨不全症的骨靶向治疗
WO2024246840A1 (en) * 2023-06-01 2024-12-05 Radius Health, Inc. Methods for identification and quantitation of abaloparatide and related peptide impurities
WO2025019691A1 (en) * 2023-07-19 2025-01-23 Zymeron Corporation Drug conjugates for bone marrow protection

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011286A1 (en) * 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
NZ506839A (en) * 1998-03-09 2003-05-30 Zealand Pharma As Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US7057012B1 (en) * 1998-12-31 2006-06-06 The General Hospital Corporation PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
JP2000327583A (ja) * 1999-05-17 2000-11-28 Medei Sci Puraningu:Kk 骨指向性ホルモン誘導体
WO2004062588A2 (en) * 2003-01-06 2004-07-29 University Of Utah Water-soluble polymeric bone-targeting drug delivery system
CA2559228C (en) * 2004-04-21 2016-06-21 Enobia Pharma Inc. Bone delivery conjugates and method of using same to target proteins to bone
US7863238B2 (en) * 2004-06-10 2011-01-04 Saint Louis University Proteins with an attached short peptide of acidic amino acids
US20110046059A1 (en) * 2005-09-06 2011-02-24 Zelos Therapeutics, Inc. Pharmaceutically acceptable formulations/compositions for peptidyl drugs
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
BRPI0719821B8 (pt) * 2006-10-03 2021-05-25 Ipsen Pharma Sas composição estável na armazenagem apropriada para administração a pacientes
CA2930681C (en) * 2007-04-09 2019-10-15 The Board Of Trustees Of The University Of Arkansas Fusion protein of collagen-binding domain and parathyroid hormone
HUE031655T2 (hu) * 2007-05-11 2017-07-28 Alexion Pharma Inc Csontot targetáló alkálikus foszfatáz, készletek és eljárások alkalmazásukra
EP2303288A4 (en) * 2008-05-22 2015-04-22 Univ Ramot CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESE MEDIUM AND ITS USE IN THE TREATMENT AND CONTROL OF ILLNESSES RELATED TO BONE
WO2012111852A1 (ja) * 2011-02-17 2012-08-23 帝人ファーマ株式会社 椎体骨折治療剤及びその評価方法
EP2699252B1 (en) * 2011-04-22 2017-10-25 Radius Health, Inc. Method of drug delivery for pth, pthrp and related peptides
CN102824647B (zh) * 2011-06-13 2014-07-23 香港中文大学 基于小核酸药物成骨治疗的骨靶向递送系统及其制备方法
EP2890708B1 (en) * 2012-08-28 2019-08-07 The Governors of the University of Alberta Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof
EP3016674A4 (en) * 2013-06-23 2017-03-15 Wisconsin Alumni Research Foundation Alpha-/beta-polypeptide analogs of parathyroid hormone (pth) and method of using same
CA2977812A1 (en) * 2015-03-03 2016-09-09 Radius Health, Inc. Uses of pthrp analogue in reducing fracture risk
US10279044B2 (en) * 2015-05-29 2019-05-07 Purdue Research Foundation Bone fracture repair by targeting of agents that promote bone healing
CN106039316B (zh) * 2016-05-03 2019-04-02 同济大学 一种基于多肽构建的成骨细胞靶向载体及其制备与应用
CA3045458A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
US20230399374A1 (en) * 2020-10-26 2023-12-14 Purdue Research Foundation Compounds, Compositions and Methods of Use to Treat Bone Fractures

Similar Documents

Publication Publication Date Title
JP2020500871A5 (https=)
JP7659015B2 (ja) 免疫調節剤としての1,2,4-オキサジアゾールおよびチアジアゾール化合物
JP2023029957A5 (https=)
JP2023029957A (ja) 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
JP2018530560A5 (https=)
UA125223C2 (uk) СПОЛУКИ БЕНЗО[b]ТІОФЕНУ ЯК АГОНІСТИ STING
JP2022518695A5 (https=)
JP2022513223A5 (https=)
JP2022514255A5 (https=)
JP2019514426A5 (https=)
KR20170125931A (ko) 면역조절제로서의 3-치환된 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
IL240686A (en) Preparations containing cyclic peptides containing adjacent arginine residues
JP2013538564A (ja) 抗ウイルス剤
JP2017538712A5 (https=)
JP2006506942A5 (https=)
NZ766762A (en) Modified lipidated relaxin b chain peptides and their therapeutic use
CZ100693A3 (en) Non-peptidic antagonists of bembesin
JP2017517253A (ja) ペプチド担体上の多重オリゴヌクレオチド部分
Krauss et al. In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide
JP2011528334A5 (https=)
US20140220074A1 (en) Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
JP2010523632A5 (https=)
JP2009507844A5 (https=)
JP2009533371A (ja) リソバクチンアミド類
JP2019506840A5 (https=)